Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Acura Pharmaceuticals (DE:HD4B)
STUTTGART:HD4B
Acura Pharmaceuticals (HD4B) Financial Statements
0 Followers
Acura Pharmaceuticals Financial Overview
| Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 270.00K | $ 613.00K | $ 644.00K | $ 718.00K | $ 410.00K |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -262.00K | $ -300.00K | $ -146.00K | $ -131.00K | $ -565.00K |
| EBITDA | $ -235.00K | $ -282.00K | $ -128.00K | $ -112.00K | $ -545.00K |
| Net Income Common Stockholders | $ -262.00K | $ -387.00K | $ -259.00K | $ -243.00K | $ -678.00K |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 89.00K | $ 167.00K | $ 361.00K | $ 413.00K | $ 493.00K |
| Total Assets | $ 1.41M | $ 1.90M | $ 1.92M | $ 1.74M | $ 2.20M |
| Total Debt | $ 324.00K | $ 601.00K | $ 6.54M | $ 6.27M | $ 6.27M |
| Net Debt | $ 235.00K | $ 434.00K | $ 6.17M | $ 5.86M | $ 5.78M |
| Total Liabilities | $ 1.27M | $ 1.51M | $ 8.05M | $ 7.63M | $ 7.86M |
| Stockholders Equity | $ 135.00K | $ 382.00K | $ -6.14M | $ -5.89M | $ -5.66M |
| Cash Flow | - | ||||
| Free Cash Flow | $ 191.00K | $ -194.00K | $ -313.00K | $ -80.00K | $ -545.00K |
| Operating Cash Flow | $ 191.00K | $ -194.00K | $ -313.00K | $ -80.00K | $ -545.00K |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | $ -269.00K | $ 0.00 | $ 261.00K | $ 0.00 | $ 0.00 |
Acura Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.